Abstract
In this issue of Cancer Research, Wu and colleagues show that IL1b orchestrates tumor-promoting inflammation in breast cancer and can be targeted in patients using an IL1 receptor antagonist. Cancer Res; 78(18); 5200–2. ©2018 AACR. See related article by Wu et al., p. 5243
Funding Information
  • NIH (AI-15614)
  • NIH (GM046883, GM113943, HD076125, HL131182, HD090637)

This publication has 11 references indexed in Scilit: